BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 30639407)

  • 1. Kaposi's sarcoma-associated herpesvirus seropositivity is associated with type 2 diabetes mellitus: A case-control study in Xinjiang, China.
    Cui M; Fang Q; Zheng J; Shu Z; Chen Y; Fan Y; Zhao J; Wood C; Zhang T; Zeng Y
    Int J Infect Dis; 2019 Mar; 80():73-79. PubMed ID: 30639407
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Social behavioral correlates of Kaposi sarcoma-associated herpesvirus infection among Han and Uygur populations in Xinjiang, China.
    Yuan H; Liu Z; Wu X; Fang Q; Zheng J; Zeng Y; Zhang T
    J Med Virol; 2019 Mar; 91(3):457-462. PubMed ID: 30281827
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of Kaposi's sarcoma-associated herpesvirus in Uygur and Han populations from the Urumqi and Kashgar regions of Xinjiang, China.
    Zheng J; Yang Y; Cui M; Shu ZJ; Han LL; Liu ZQ; Wood C; Zhang T; Zeng Y
    Virol Sin; 2017 Oct; 32(5):396-403. PubMed ID: 29116591
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Seroprevalence of Kaposi's sarcoma-associated herpesvirus and risk factors in Xinjiang, China.
    Fu B; Sun F; Li B; Yang L; Zeng Y; Sun X; Xu F; Rayner S; Guadalupe M; Gao SJ; Wang L
    J Med Virol; 2009 Aug; 81(8):1422-31. PubMed ID: 19551832
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence of Kaposi's sarcoma associated herpesvirus among men attending sexually transmitted infections clinics in Anhui, China.
    Wang J; Liu S; Cao Y; Yang L; Chen Y; Minhas V; Wood C; Zhang T
    J Med Virol; 2016 Feb; 88(2):304-11. PubMed ID: 26147809
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Seroprevalence and risk factors of Kaposi's sarcoma-associated herpesvirus infection among the general Uygur population from south and north region of Xinjiang, China.
    Wang H; Liu J; Dilimulati ; Li L; Ren Z; Wen H; Wang X
    Virol J; 2011 Dec; 8():539. PubMed ID: 22168313
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk factors influencing antibody responses to Kaposi's sarcoma-associated herpesvirus latent and lytic antigens in patients under antiretroviral therapy.
    Guadalupe M; Pollock BH; Westbrook S; Redding S; Bullock D; Anstead G; Agan BK; Marconi VC; Barbieri S; Sankar V; Rebeles J; Flahive Y; Schoolfield J; Wang L; Lei X; Dow D; Yeh CK; Dang H; Infante AJ; Gao SJ
    J Acquir Immune Defic Syndr; 2011 Jan; 56(1):83-90. PubMed ID: 21084997
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Classic type of Kaposi's sarcoma and human herpesvirus 8 infection in Xinjiang, China.
    Dilnur P; Katano H; Wang ZH; Osakabe Y; Kudo M; Sata T; Ebihara Y
    Pathol Int; 2001 Nov; 51(11):845-52. PubMed ID: 11844050
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Infection with Kaposi's sarcoma-associated herpesvirus among families of patients with classic Kaposi's sarcoma.
    Guttman-Yassky E; Kra-Oz Z; Dubnov J; Friedman-Birnbaum R; Segal I; Zaltzman N; Roth T; Schwartz F; Linn S; Rozenman D; David M; Silbermann M; Barchana M; Bergman R; Sarid R
    Arch Dermatol; 2005 Nov; 141(11):1429-34. PubMed ID: 16301390
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Kaposi's sarcoma-associated herpesvirus seroprevalence in selected german patients: evaluation by different test systems.
    Preiser W; Szép NI; Lang D; Doerr HW; Rabenau HF
    Med Microbiol Immunol; 2001 Dec; 190(3):121-7. PubMed ID: 11827200
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human herpesvirus 8: serovprevalence and correlates in tumor patients from Xinjiang, China.
    He F; Wang X; He B; Feng Z; Lu X; Zhang Y; Zhao S; Lin R; Hui Y; Bao Y; Zhang Z; Wen H
    J Med Virol; 2007 Feb; 79(2):161-6. PubMed ID: 17177299
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Seroprevalence of Kaposi's sarcoma-associated herpesvirus and risk factors in Jiuquan area, China.
    Fang Y; Li W; Zhang Y; Zhou C; Wu H; Zhang Y; Dai T; Wang J; Wang L; Chen T; Zhu Y; Wang L
    J Med Virol; 2022 Dec; 94(12):6016-6022. PubMed ID: 35922376
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk factors for Kaposi's sarcoma among HIV-positive individuals in a case control study in Cameroon.
    Stolka K; Ndom P; Hemingway-Foday J; Iriondo-Perez J; Miley W; Labo N; Stella J; Abassora M; Woelk G; Ryder R; Whitby D; Smith JS
    Cancer Epidemiol; 2014 Apr; 38(2):137-43. PubMed ID: 24631417
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Seroprevalence of Kaposi's sarcoma-associated herpesvirus among men who have sex with men in Japan.
    Katano H; Yokomaku Y; Fukumoto H; Kanno T; Nakayama T; Shingae A; Sugiura W; Ichikawa S; Yasuoka A
    J Med Virol; 2013 Jun; 85(6):1046-52. PubMed ID: 23588730
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intrafamiliar transmission of Kaposi's sarcoma-associated herpesvirus and seronegative infection in family members of classic Kaposi's sarcoma patients.
    Mancuso R; Brambilla L; Agostini S; Biffi R; Hernis A; Guerini FR; Agliardi C; Tourlaki A; Bellinvia M; Clerici M
    J Gen Virol; 2011 Apr; 92(Pt 4):744-51. PubMed ID: 21216985
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Environmental risk factors and genetic markers of Kaposi's sarcoma-associated herpesvirus infection among Uygur population in Xinjiang, China.
    Zhang X; Fang Q; Zhu S; Wu X; Yuan H; Liu Z; Xu Y; Chen T; Zeng Y; Zhang T
    J Med Virol; 2022 Jun; 94(6):2755-2765. PubMed ID: 35043408
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genotypic analysis of Kaposi's sarcoma-associated herpesvirus from patients with Kaposi's sarcoma in Xinjiang, China.
    Ouyang X; Zeng Y; Fu B; Wang X; Chen W; Fang Y; Luo M; Wang L
    Viruses; 2014 Nov; 6(12):4800-10. PubMed ID: 25431948
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence of Kaposi's sarcoma associated herpesvirus infection measured by antibodies to recombinant capsid protein and latent immunofluorescence antigen.
    Simpson GR; Schulz TF; Whitby D; Cook PM; Boshoff C; Rainbow L; Howard MR; Gao SJ; Bohenzky RA; Simmonds P; Lee C; de Ruiter A; Hatzakis A; Tedder RS; Weller IV; Weiss RA; Moore PS
    Lancet; 1996 Oct; 348(9035):1133-8. PubMed ID: 8888167
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk factors for Kaposi's sarcoma: a case-control study of HIV-seronegative people in Uganda.
    Ziegler J; Newton R; Bourboulia D; Casabonne D; Beral V; Mbidde E; Carpenter L; Reeves G; Parkin DM; Wabinga H; Mbulaiteye S; Jaffe H; Weiss R; Boshoff C;
    Int J Cancer; 2003 Jan; 103(2):233-40. PubMed ID: 12455038
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Seroreactivity to Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) latent nuclear antigen in AIDS-associated Kaposi's sarcoma patients depends on CD4+ T-cell count.
    de Souza VA; Pierrotti LC; Sumita LM; Freire WS; Segurado AA; Pannuti CS
    J Med Virol; 2007 Oct; 79(10):1562-8. PubMed ID: 17705173
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.